Effects of different doses of metformin on bone mineral density and bone metabolism in elderly male patients with type 2 diabetes mellitus

Glucose starvation induces resistance to metformin through the elevation of mitochondrial multidrug resistance protein 1

(2019) Sung-Hyun Hwang et al.   CANCER SCIENCE

Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials

(2019) Ze Chen et al.   CLINICAL DRUG INVESTIGATION

Metformin and risk of chronic obstructive pulmonary disease in diabetes patients

(2018) C.-H. Tseng   DIABETES & METABOLISM

Effects of liraglutide, metformin, and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: a randomized trial

(2018) Wen-Huan Feng et al.   Journal of Diabetes Investigation

Cystatin C measurement leads to lower metformin dosage in elderly type 2 diabetic patients

(2018) Tomáš Šálek et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials

(2018) Yan Peng et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis

(2018) Sha Zeng et al.   MEDICINA CLINICA

Diabetes Care for Patients Experiencing Homelessness: Beyond Metformin and Sulfonylureas

(2018) Lauren K. Brooks et al.   AMERICAN JOURNAL OF MEDICINE

Comparison of a twice daily injection of insulin aspart 50 with insulin aspart 30 in patients with poorly controlled type 2 diabetes

(2018) Chunhong Shi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effect of metformin treatment in patients with type 2 diabetes with respect to glyoxalase 1 activity in atherosclerotic lesions

(2018) Andreas S. Peters et al.   Vasa-European Journal of Vascular Medicine

Dose-ranging efficacy and safety study of ertugliflozin, a sodium-glucose co-transporter 2 inhibitor, in patients with type 2 diabetes on a background of metformin

(2015) N. B. Amin et al.   DIABETES OBESITY & METABOLISM

Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus

(2015) TAMER AHMED ISMAIL et al.   Experimental and Therapeutic Medicine

Metformin Suppresses Lipid Accumulation in Skeletal Muscle by Promoting Fatty Acid Oxidation

(2014) Chao Wang et al.   Clinical Laboratory

Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naïve patients with type 2 diabetes: a randomized, double-blind, 6-month study

(2014) R. E. Pratley et al.   DIABETES OBESITY & METABOLISM

Comparative effects of sitagliptin and metformin in patients with type 2 diabetes mellitus: a meta-analysis

(2013) Qiang Du et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis

(2013) D. Wu et al.   DIABETES OBESITY & METABOLISM

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin

(2013) J. Bolinder et al.   DIABETES OBESITY & METABOLISM